Xiaohui Liang Selected Research

Xiaohui Liang Research Topics

Disease

21	Neoplasms (Cancer) 12/2023 - 05/2008
12	Breast Neoplasms (Breast Cancer) 04/2024 - 05/2006
6	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2014
4	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 02/2017
3	Lung Neoplasms (Lung Cancer) 11/2022 - 04/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 01/2013
2	Triple Negative Breast Neoplasms 08/2019 - 01/2017
1	Pneumonia (Pneumonitis) 10/2022
1	Dementia (Dementias) 05/2022
1	Fahr's disease 02/2022
1	Lupus Nephritis 02/2022
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Necrosis 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Communicable Diseases (Infectious Diseases) 06/2020
1	COVID-19 06/2020
1	Lymphatic Metastasis 04/2017
1	Adenocarcinoma of Lung 01/2017
1	Carcinogenesis 07/2016
1	Hypoxia (Hypoxemia) 07/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2016
1	Ankylosing Spondylitis 08/2013
1	Hypertension (High Blood Pressure) 05/2013
1	Essential Hypertension 05/2013
1	Circulating Neoplastic Cells 01/2013
1	Chondrosarcoma 07/2012
1	Chondroma (Enchondroma) 07/2012
1	Genomic Instability 07/2010

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 04/2024 - 04/2017
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2009
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 07/2016
2	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 07/2010
2	Messenger RNA (mRNA)IBA 01/2017 - 05/2008
2	RNA Splicing FactorsIBA 01/2017 - 01/2017
2	Small Interfering RNA (siRNA)IBA 07/2016 - 07/2010
2	RetinoidsIBA 07/2016 - 09/2007
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2024
1	Orphan Nuclear ReceptorsIBA 04/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2024
1	Peptides (Polypeptides)IBA 04/2024
1	polydopamineIBA 12/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2023
1	Dopamine (Intropin)FDA LinkGeneric 12/2023
1	poly(3- hydroxybutyrate)- co- (3- hydroxyvalerate)IBA 12/2023
1	snake venom protein C activatorIBA 11/2023
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2023
1	Cell-Free Nucleic AcidsIBA 11/2022
1	Tyrosine Kinase InhibitorsIBA 11/2022
1	calcium phosphateIBA 02/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	galanginIBA 01/2021
1	helichrysetinIBA 01/2021
1	FlavonoidsIBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	cardamoninIBA 08/2019
1	Chalcone (Benzalacetophenone)IBA 08/2019
1	cadherin 5IBA 01/2019
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2019
1	Adiponectin ReceptorsIBA 04/2017
1	Progesterone FDA LinkGeneric 04/2017
1	Transcription Factors (Transcription Factor)IBA 02/2017
1	Galectin 3 (LGALS3)IBA 02/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2017
1	CateninsIBA 01/2017
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2017
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2017
1	Cell Adhesion MoleculesIBA 01/2017
1	Insulin-Like PeptidesIBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Phenobarbital (Luminal)FDA Link 10/2016
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 10/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2016
1	InterferonsIBA 07/2016
1	Protein Kinases (Protein Kinase)IBA 07/2016
1	HLA-B Antigens (HLA-B)IBA 08/2013
1	ElectrolytesIBA 05/2013
1	Atrial Natriuretic Factor (ANF)IBA 05/2013
1	PotassiumIBA 05/2013
1	LigandsIBA 01/2013
1	OligonucleotidesIBA 01/2013
1	ParaffinIBA 07/2012
1	Aurora Kinase AIBA 07/2012
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2007

Therapy/Procedure

8	Therapeutics 04/2024 - 05/2006
3	Drug Therapy (Chemotherapy) 01/2017 - 01/2014
1	Photochemotherapy (Photodynamic Therapy) 10/2011